Abstract

One in four community-dwelling older adults is prescribed an inappropriate medication. Educational interventions aimed at patients to reduce inappropriate medications may cause patients to question their prescriber’s judgment. The objective of this study was to determine whether a patient-focused deprescribing intervention compromised trust between older adults and their healthcare providers. An educational brochure was distributed to community-dwelling older adults by community pharmacists in order to trigger deprescribing conversations. At baseline and 6-months post-intervention, participants completed the Primary Care Assessment Survey, which measures patient trust in doctors and pharmacists. Changes in trust were ascertained post-intervention. Proportions with 95% confidence intervals (CI), and logistic regression were used to determine a shift in trust and associated predictors. 352 participants responded to the questionnaire at both time points. The majority of participants had no change or gained trust in their doctors for items related to the choice of medical care (78.5%, 95% CI = 74.2–82.8), communication transparency (75.4%, 95% CI = 70.7–79.8), and overall trust (81.9%, 95% CI = 77.9–86.0). Similar results were obtained for participants’ perceptions of their pharmacists, with trust remaining intact for items related to the choice of medical care (79.4%, 95% CI = 75.3–83.9), transparency in communicating (82.0%, 95% CI = 78.0–86.1), and overall trust (81.6%, 95% CI = 77.5–85.7). Neither age, sex nor the medication class targeted for deprescribing was associated with a loss of trust. Overall, the results indicate that patient-focused deprescribing interventions do not shift patients’ trust in their healthcare providers in a negative direction.

Highlights

  • With increasing age comes an accumulation of comorbidities [1,2], medications [3], and potentially inappropriate prescriptions [4]

  • Results from the first 352 participants enrolled in the trial were analyzed for this study as part of a preliminary analysis of the D-PRESCRIBE trial

  • At one week post-intervention, 62.5% of participants intended to speak to a healthcare provider about making changes to their medication, while 37.5% had no intention of doing so

Read more

Summary

Introduction

With increasing age comes an accumulation of comorbidities [1,2], medications [3], and potentially inappropriate prescriptions [4]. Use of potentially inappropriate medications such as benzodiazepines has been associated with a higher risk of falls, fractures, cognitive impairment and mortality in older adults [7,8,9,10,11,12]. Patient education about medication harms is a novel method to drive conversations around deprescribing inappropriate medications. Pharmacy 2018, 6, 31 successful in reducing inappropriate benzodiazepine use in community-dwelling older adults by. Almost two-thirds of recipients initiated a conversation about deprescribing with their healthcare provider after receipt of the intervention. One reason stated by some participants for not opting to discuss discontinuation was trust in their healthcare provider’s decision to prescribe the medication in the first place [14].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call